molybdenum has been researched along with Nervous System Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askari, F; Brewer, GJ; Carlson, M; Dick, RB; Fink, JK; Hedera, P; Kluin, KJ; Sitterly, J | 1 |
| Brewer, GJ | 1 |
| Beemer, FA; Duran, M; Johnson, JL; Rajagopalan, KV; Wadman, SK; Waud, WR | 1 |
| Artigas, M; Coll, MJ; Johnson, JL; Naranjo, MA; Pintos-Morell, G; Rajagopalan, KV; Rodes, M; Roge, M | 1 |
| Scheinberg, IH; Sternlieb, I | 1 |
| Aisen, A; Brewer, GJ; Dick, RD; Fink, JK; Johnson, V; Kluin, K; Wang, Y; Yuzbasiyan-Gurkan, V | 1 |
| Bellini, C; Bertola, A; Bonioli, E; Caruso, U; DiStefano, A; Dorche, C; Fantasia, AR; Minniti, G; Palmieri, A | 1 |
| Kaku, S; Matsumoto, H; Shiramizu, M; Tateishi, M; Yamaguchi, S | 1 |
| Duch, DS; Nichol, CA; Smith, GK | 1 |
| Eolian, SL | 1 |
2 review(s) available for molybdenum and Nervous System Diseases
| Article | Year |
|---|---|
Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
Topics: Behavior; Chelating Agents; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillamine; Trientine; Zinc | 2005 |
Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.
Topics: Alcohol Oxidoreductases; Animals; Biopterins; Body Fluids; Coenzymes; GTP Cyclohydrolase; Humans; Immune System Diseases; Mental Disorders; Metalloproteins; Molybdenum; Molybdenum Cofactors; Neoplasms; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines; Pterins; Tetrahydrofolate Dehydrogenase; Tissue Distribution; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1985 |
1 trial(s) available for molybdenum and Nervous System Diseases
| Article | Year |
|---|---|
Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.
Topics: Adult; Child; Enzyme Inhibitors; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Molybdenum; Nervous System Diseases; Neurologic Examination; Treatment Outcome; Zinc | 2003 |
7 other study(ies) available for molybdenum and Nervous System Diseases
| Article | Year |
|---|---|
Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor.
Topics: Child, Preschool; Coenzymes; Female; Fibroblasts; Humans; Immunologic Techniques; Intellectual Disability; Ketone Oxidoreductases; Lens Subluxation; Liver; Metal Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Xanthine Dehydrogenase | 1980 |
Molybdenum cofactor deficiency associated with Dandy-Walker malformation.
Topics: Coenzymes; Dandy-Walker Syndrome; Humans; Infant, Newborn; Kidney Calculi; Lens Subluxation; Male; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Pteridines; Ultrasonography | 1995 |
Treatment of the neurologic manifestations of Wilson's disease.
Topics: Dimercaprol; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillamine | 1995 |
Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Molybdenum; Nervous System Diseases; Trichloroacetic Acid | 1994 |
Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor.
Topics: Coenzymes; Female; Fibroblasts; Humans; Hypoxanthine; Infant; Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines | 1996 |
Factors affecting the amount of mercury in human scalp hair.
Topics: Chromatography, Gas; Diet; Environmental Exposure; Female; Fish Products; Food Contamination; Hair; Hospitalization; Humans; India; Industrial Waste; Japan; Male; Mercury; Mercury Poisoning; Metallurgy; Methylmercury Compounds; Molybdenum; Nepal; Nervous System Diseases; Occupational Medicine; Spectrophotometry, Atomic; United States | 1975 |
[On the effect of molybdenum (molybdenite) on the nervous system].
Topics: Adult; Humans; Male; Molybdenum; Nervous System Diseases; Occupational Diseases | 1965 |